EUVIMEDEUVIMED entdecken
Open Access

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis

Bader Faiyaz Zuberi, Faiza Sadaqat Ali, Tazeen Rasheed, Nimrah Bader

Pakistan Journal of Medical Sciences · 05.03.2026 · 42 (3) · 599-603

DOI: 10.12669/pjms.42.3.12534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 05.03.2026. Verfasst von Bader Faiyaz Zuberi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bader Faiyaz Zuberi, FCPS. Meritorious Professor, OMI Hospital, Karachi, Sindh, Pakistan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine on-treatment changes in MELD-Na & Fibroscan scores after a period of six months in patients with chronic Hepatitis-B who are treated with Entecavir (ETV). Methodology: This observational cohort was conducted at Department of Medicine/Gastroenterology, Dow Medical College affiliated with Dow University of Health Sciences, Karachi, Pakistan during the period of August 2019 to December 2024. Patients of either gender aged between 18 - 80 years attending hepatitis clinic and who are on treatment for Hepatitis-B with Entecavir were inducted after informed consent. MELD-Na & Fibroscan scores were recorded at induction and after six months of treatment with ETV.

Results

A total of 288 patients were enrolled including 153 (53.1%) were males with mean age of 37.6 ±11.6 years and 135 (46.9%) were females with mean age of 43.5 ±9.6 years. The difference in age between genders was significant (p < .001). Comparison of parameters at induction of study and after six months of treatment with Entecavir using Paired Sample T-Test, we found significant improvement in all parameters except serum albumin which showed significant reduction in levels after six months. MELD-Na Score improved from 9.38 to 8.94 (p

Schlagwörter

Stichwörter der Autor:innen

Chronic Liver DiseaseFibroscanHepatitis-BMELD-Na

Autor:innen und Institutionen

  • Bader Faiyaz Zuberi, FCPS. Meritorious Professor, OMI Hospital, Karachi, Sindh, Pakistan.
  • Faiza Sadaqat Ali, FCPS Senior Registrar, Department of Medicine/Gastroenterology, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
  • Tazeen Rasheed, FCPS Associate Professor, Department of Medicine/Gastroenterology, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
  • Nimrah Bader, MD Assistant Professor, Department of Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA.

Zitieren

APA

Zuberi, B. F., Ali, F. S., Rasheed, T., & Bader, N. (2026). Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. Pakistan Journal of Medical Sciences, 42(3), 599-603. https://doi.org/10.12669/pjms.42.3.12534

Vancouver

Zuberi BF, Ali FS, Rasheed T, Bader N. Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. Pakistan Journal of Medical Sciences. 2026;42(3):599-603. doi:10.12669/pjms.42.3.12534

BibTeX
@article{Zuberi2026,
  author = {Zuberi, Bader Faiyaz and Ali, Faiza Sadaqat and Rasheed, Tazeen and Bader, Nimrah},
  title = {Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis},
  journal = {Pakistan Journal of Medical Sciences},
  year = {2026},
  volume = {42},
  number = {3},
  pages = {599--603},
  doi = {10.12669/pjms.42.3.12534}
}
Kostenlos starten →